Рецензия на книгу
Darm mit Charme: Alles über ein unterschätztes Organ
Giulia Enders
russell203022 января 2020 г.список литературы
Что интересно в русской версии не включили список литературы на которую ссылается автор. В английской версии список присутствует.
Part One
Bandani, A.R.: “Effect of Plant a-Amylase Inhibitors on Sunn Pest, Eurygaster
Integriceps Puton (Hemiptera: Scutelleridae), Alpha-Amylase Activity.” In:
Commun Agric Appl Biol Sci. 2005; 70 (4): pp. 869–873.
Baugh, R.F. et al.: “Clinical Practice Guideline: Tonsillectomy in Children.” In:
Otolaryngol Head Neck Surg. 2011 January; 144 (Suppl. 1): pp. 1–30.
Bengmark, S.: “Integrative Medicine and Human Health—The Role of Pre-,
Pro- and Synbiotics.” In: Clin Transl Med. 2012 May 28; 1 (1): p. 6.
Bernardo, D et al.: “Is Gliadin Really Safe for Non-Coeliac Individuals? Pro-
duction of Interleukin 15 in Biopsy Culture from Non-Coeliac Individuals
Challenged with Gliadin Peptides.” In: Gut. 2007 June; 56 (6): p. 889 f.
Bodinier, M. et al.: “Intestinal Translocation Capabilities of Wheat Allergens
Using the Caco-2 Cell Line.” In: J Agric Food Chem. 2007 May 30; 55 (11):
pp. 4576–4583.
Bollinger, R. et al.: “Biofilms in the Large Bowel Suggest an Apparent Func-
tion of the Human Vermiform Appendix.” In: J Theor Biol. 2007 December
21; 249 (4): pp. 826–831.
Catassi, C. et al.: “Non-Celiac Gluten Sensitivity: The New Frontier of Gluten
Related Disorders.” In: Nutrients. 2013 September 26; 5 (10): pp. 3839–3853.
Kim, B.H.; Gadd, G.M.: Bacterial Physiology and Metabolism. Cambridge: Cam-
bridge University Press, 2008.
Klausner, A.G. et al.: “Behavioral Modification of Colonic Function. Can Con-
stipation Be Learned?” In: Dig Dis Sci. 1990 October; 35 (10): pp. 1271–1275.
Lammers, K.L. et al.: “Gliadin Induces an Increase in Intestinal Permeability
and Zonulin Release by Binding to the Chemokine Receptor cXcr3.” In:
Gastroenterology. 2008 July; 135 (1): pp. 194–204.
Ledochowski, M. et al.: “Fructose- and Sorbitol-Reduced Diet Improves Mood
and Gastrointestinal Disturbances in Fructose Malabsorbers.” In: Scand J
Gastroenterol. 2000 October; 35 (10): pp. 1048–1052.
Lewis, S.J.; Heaton, K.W.: “Stool Form Scale as a Useful Guide to Intestinal Tran-
sit Time.” In: Scand J Gastroenterol. 1997 September; 32 (9): pp. 920–924.
Martín-Peláez, S. et al.: “Health Effects of Olive Oil Polyphenols: Recent
Advances and Possibilities for the Use of Health Claims.” In: Mol. Nutr.
Food Res. 2013; 57 (5): pp. 760–771.
Paul, S.: Paläopower—Das Wissen der Evolution nutzen für Ernährung, Gesund-
heit und Genuss. Munich: C.H. Beck-Verlag, 2013 (2nd Edition). (In German)
Sikirov, D.: “Etiology and Pathogenesis of Diverticulosis Coli: A New
Approach.” In: Med Hypotheses. 1988 May: 26 (1): pp. 17–20.
Sikirov, D.: “Comparison of Straining during Defecation in Three Positions:
Results and Implications for Human Health.” In: Dig Dis Sci. 2003 July; 48
(7): pp. 1201–1205.
Thorleifsdottir, R.H. et al.: “Improvement of Psoriasis after Tonsillectomy Is
Associated with a Decrease in the Frequency of Circulating T Cells That
Recognize Streptococcal Determinants and Homologous Skin Determi-
nants.” In: J Immunol. 2012; 188 (10): pp. 5160–5165.
Varea, V. et al.: “Malabsorption of Carbohydrates and Depression in Children
and Adolescents.” In: J Pediatr Gastroenterol Nutr. 2005 May; 40 (5): pp.
561–565.
Wisner, A. et al.: “Human Opiorphin, a Natural Antinociceptive Modulator of
Opioid-Dependent Pathways.” In: Proc Natl Acad Sci USA. 2006 November
21; 103 (47): pp. 17979–17984.Part Two
Aguilera, M. et al.: “Stress and Antibiotics Alter Luminal and Wall-Adhered
Microbiota and Enhance the Local Expression of Visceral Sensory-
Related Systems in Mice.” In: Neurogastroenterol Motil. 2013 August; 25 (8):
pp. e515–e529.
Bercik, P. et al.: “The Intestinal Microbiota Affect Central Levels of Brain-
Derived Neurotropic Factor and Behavior in Mice.” In: Gastroenterology.
2011 August; 141 (2): pp. 599–609.
Bravo, J.A. et al.: “Ingestion of Lactobacillus Strain Regulates Emotional
Behavior and Central gaBa Receptor Expression in a Mouse via the
Vagus Nerve.” In: Proc Natl Acad Sci USA. 2011 September 20; 108 (38): pp.
16050–16055.
Bubenzer, R.H.; Kaden, M.: at www.sodbrennen-welt.de (retrieved October
2013).
Castrén, E.: “Neuronal Network Plasticity and Recovery from Depression.” In:
JAMA Psychiatry. 2013: 70 (9): pp. 983–989.
Craig, A.D.: “How Do You Feel—Now? The Anterior Insula and Human Aware-
ness.” In: Nat Rev Neurosci. 2009 January; 10 (1): pp. 58–70.
Enck, P. et al.: “Therapy Options in Irritable Bowel Syndrome.” In: Eur J Gas-
troenterol Hepatol. 2010 December; 22 (12): pp. 1402–1411.
Furness, J.B. et al.: “The Intestine as a Sensory Organ: Neural, Endocrine, and
Immune Responses.” In: Am J Physiol Gastrointest Liver Physiol. 1999; 227
(5): pp. g922–g928.
Huerta-Franco, M.R. et al.: “Effect of Psychological Stress on Gastric Motility
Assessed by Electrical Bio-Impedance.” In: World J Gastroenterol. 2012 Sep-
tember 28; 18 (36): pp. 5027–5033.
Kell, C.A. et al.: “The Sensory Cortical Representation of the Human Penis:
Revisiting Somatotopy in the Male Homunculus.” In: J Neurosci. 2005
June 22; 25 (25): pp. 5984–5987.
Keller, J. et al.: “s3-Leitline der Deutschen Gesellschaft für Verdauungs- und
Stoffwechselkrankheiten (dgVs) und der Deutschen Gesellschaft für
Neurogastroenterologie und Motilität (dgnM) zu Definition, Pathophys-
iologie, Diagnostik und Therapie intestinaler Motilitätsstörungen” [S3
Guidelines of the German Society for Digestive and Metabolic Diseases (DGVS)
and the German Society for Neurogastroenterology and Motility (DGNM) for
the Definition, Pathophysiology, Diagnosis, and Treatment of Intestinal Motil-
ity Disorders]. In: Z Gastroenterol. 2011; 49: pp. 374–390. (In German)
Keywood, C. et al.: “A Proof of Concept Study Evaluating the Effect of
adX10059, a Metabotropic Glutamate Receptor-5 Negative Allosteric
Modulator, on Acid Exposure and Symptoms in Gastro-Oesophageal
Reflux Disease.” In: Gut. 2009 September; 58 (9): pp. 1192–1199.
Krammer, H. et al.: “Tabuthema Obstipation: Welche Rolle spielen Lebens-
gewohnheiten, Ernährung, Prä- und Probiotika sowie Laxanzien?” [Taboo
Subject Constipation: What Part Do Habits, Diet, Pre- and Probiotics, and Lax-
atives Play?]. In: Aktuelle Ernährungsmedizin. 2009; 34 (1): pp. 38–46. (In
German)
Layer, P. et al.: “s3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiol-
ogie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen
Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (dgVs) und
der Deutschen Gesellschaft für Neurogastroenterologie und Motilität
(dgnM)” [S3 Guideline on Irritable Bowel Syndrom: Joint Guideline of the
German Society for Digestive and Metabolic Diseases (DGVS) and the German
Society for Neurogastroenterology and Motility (DGNM)]. In: Z Gastroenterol.
2011; 49: pp. 237–293. (In German)
Ma, X. et al.: “Lactobacillus Reuteri Ingestion Prevents Hyperexcitability of
Colonic drg Neurons Induced by Noxious Stimuli.” In: Am J Physiol Gas-
trointest Liver Physiol. 2009 April; 296 (4): pp. g868–g875.
Mayer, E.A.: “Gut Feelings: The Emerging Biology of Gut-Brain Communica-
tion.” In: Nat Rev Neurosci. 2011 July 13; 12 (8): pp. 453–466.
Mayer, E.A. et al.: “Brain Imaging Approaches to the Study of Functional gi
Disorders: A Rome Working Team Report.” In: Neurogastroenterol Motil.
2009 June; 21 (6): pp. 579–596.
Moser, G. (Ed.): Psychosomatik in der Gastroenterologie und Hepatologie [Psy-
chosomatics in Gastroenterology and Hepatology]. Vienna; New York:
Springer, 2007. (In German)
Naliboff, B.D. et al.: “Evidence for Two Distinct Perceptual Alterations in Irri-
table Bowel Syndrom.” In: Gut. 1997 October; 41 (4): pp. 505–512.
Palatty, P.L. et al.: “Ginger in the Prevention of Nausea and Vomiting: A
Review.” In: Crit Rev Food Sci Nutr. 2013; 53 (7): pp. 659–669.
Reveiller, M. et al.: “Bile Exposure Inhibits Expression of Squamous Differen-
tiation Genes in Human Esophageal Epithelial Cells.” In: Ann Surg. 2012
June; 255 (6): pp. 1113–1120.
Revenstorf, D.: Expertise zur wissenschaftlichen Evidenz der Hypnotherapie
[Expert Opinion on the Scientific Evidence for Hypnotherapy]. Tübin-
gen, 2003; at https://www.meg.tuebingen.de/downloads/Expertise.pdf
(retrieved October 2013). (In German)
Simons, C.C. et al.: “Bowel Movement and Constipation Frequencies and the
Risk of Colorectal Cancer among Men in the Netherlands Cohort Study
on Diet and Cancer.” In: Am J Epidemiol. 2010 December 15; 172 (12): pp.
1404–1414.
Streitberger, K. et al.: “Acupuncture Compared to Placebo-Acupuncture for
Postoperative Nausea and Vomiting Prophylaxis: A Randomised Placebo-
Controlled Patient and Observer Blind Trial.” In: Anaesthesia. 2004 Febru-
ary; 59 (2): pp. 142–149.
Tillisch, K. et al.: “Consumption of Fermented Milk Product with Probiotic
Modulates Brain Activity.” In: Gastroenterology. 2013 June; 144 (7): pp.
1394–1401.
Part Three
Aggarwal, J. et al.: “Probiotics and their Effects on Metabolic Diseases: An
Update.” In: J Clin Diagn Res. 2013 January; 7 (1): pp. 173–177.
Arnold, I.C. et al.: “Helicobacter pylori Infection Prevents Allergic Asthma in
Mouse Models through the Induction of Regulatory T Cells.” In: J Clin
Invest. 2011 August; 121 (8): pp. 3088–3093.
Arumugam, M. et al.: “Enterotypes of the Human Gut Microbiome.” In:
Nature. 2011 May 12; 474 (7353); 1: pp. 174–180.
Bäckhed, F.: “Addressing the Gut Microbiome and Implications for Obesity.”
In: International Dairy Journal. 2012; 20 (4): pp. 259–261.
Balakrishnan, M.; Floch, M.H.: “Prebiotics, Probiotics and Digestive Health.”
In: Curr Opin Clin Nutr Metab Care. 2012 November; 15 (6): pp. 580–585.
Barros, F.C.: “Cesarean Section and Risk of Obesity in Childhood, Adolescence,
and Early Adulthood: Evidence from 3 Brazilian Birth Cohorts.” In: Am J
Clin Nutr. 2012; 95 (2): pp. 465–470.
Bartolomeo, F. Di: “Prebiotics to Fight Diseases: Reality of Fiction?” In: Phyto-
ther Res. 2013 October; 27 (10): pp. 1457–1473.
Bischoff, S.C.; Köchling, K.: “Pro- und Präbiotika” [Pro- and Prebiotics]. In:
Zeitschrift für Stoffwechselforschung, klinische Ernährung und Diätik. 2012;
37: pp. 287–304.
Borody, T.J. et al.: “Fecal Microbiota Transplantation: Indications, Meth-
ods, Evidence, and Future Directions.” In: Curr Gastroenterol Rep. 2013; 15
(8): p. 337.
Bräunig, J.: Verbrauchertipps zu Lebensmittelhygiene, Reinigung und Desinfek-
tion [Consumer Tips on Food Hygiene, Cleaning and Disinfection]. Berlin:
German Federal Institute for Risk Assessment, 2005. (In German)
Brede C.: Das Instrument der Sauberkeit. Die Entwicklung der Massenproduktion
von Feinseifen in Deutschland 1850 to 2000 [The Instrument of Cleanliness.
The Development of Fine Soap Mass Production in Germany 1850 to
2000]. Münster et al.: Waxmann, 2005. (In German)
Caporaso, J.G. et al.: “Moving Pictures of the Human Microbiome.” In: Genome
Biol. 2011; 12 (5): p. r50.
Carvalho, B.M.; Saad, M.J.: “Influence of Gut Microbiota on Subclinical
Inflammation and Insulin Resistance.” In: Mediators Inflamm. 2013; 2013:
986734.
Charalampopoulos, D.; Rastall, R.A.: “Prebiotics in Foods.” In: Current Opinion
on Biotechnology. 2012, 23 (2): pp. 187–191.
Chen, Y. et al.: “Association between Helicobacter pylori and Mortality in the
nhanes iii Study.” In: Gut. 2013 September; 62 (9): pp. 1262–1269.
Devaraj, S. et al.: “The Human Gut Microbiome and Body Metabolism: Impli-
cations for Obesity and Diabetes.” In: Clin Chem. 2013 April; 59 (4): pp.
617–628.
Dominguez-Bello, M.G. et al.: “Development of the Human Gastrointestinal
Microbiota and Insights from High-Throughput Sequencing.” In: Gastro-
enterology. 2011 May; 140 (6): pp. 1713–1791.
Douglas, L.C.; Sanders, M.E.: “Probiotics and Prebiotics in Dietetics Practice.”
In: J Am Diet Assoc. 2008 March; 108 (3): pp. 510–521.
Eppinger, M. et al.: “Who Ate Whom? Adaptive Helicobacter Genomic Changes
That Accompanied a Host Jump from Early Humans to Large Felines.” In:
PLoS Genet. 2006 July; 2 (7): p. e120.
Fahey, J.W. et al.: “Urease from Helicobacter pylori Is Inactivated by Sulfora-
phane and Other Isothiocyanates.” In: Biochem Biophys Res Commun. 2013
May 24; 435 (1): pp. 1–7.
Flegr, J.: “Influence of Latent Toxoplasma Infection on Human Personality,
Physiology and Morphology: Pros and Cons of the Toxoplasma-Human
Model in Studying the Manipulation Hypothesis.” In: J Exp Biol. 2013 Jan-
uary 1; 216 (Pt. 1): pp. 127–133.
Flegr, J. et al.: “Increased Incidence of Traffic Accidents in Toxoplasma-
Infected Military Drivers and Protective Effect RhD Molecule Revealed by
a Large-Scale Prospective Cohort Study.” In: BMC Infect Dis. 2009 May 26;
9: p. 72.
Flint, H.J.: “Obesity and the Gut Microbiota.” In: J Clin Gastroenterol. 2011
November; 45 (Suppl.): pp. 128–132.
Fouhy, F. et al.: “High-Throughput Sequencing Reveals the Incomplete,
Short-Term Recovery of Infant Gut Microbiota following Parenteral Anti-
biotic Treatment with Ampicillin and Gentamicin.” In: Antimicrob Agents
Chemother. 2012 November; 56 (11): pp. 5811–5820.
Fuhrer, A. et al.: “Milk Sialyllactose Influences Colitis in Mice through Selec-
tive Intestinal Bacterial Colonization.” In: J Exp Med. 2010 December 20;
207 (13): pp. 2843–2854.
Gale, E.A.M.: “A Missing Link in the Hygiene Hypothesis?” In: Diabetologia.
2002; 45 (4): pp. 588–594.
Ganal, S.C. et al.: “Priming of Natural Killer Cells by Non-Mucosal Mono-
nuclear Phagocytes Requires Instructive Signals from the Commensal
Microbiota.” In: Immunity. 2012 July 27; 37 (1): pp. 171–186.
German Federal Government: “Antwort der Bundesregierung auf die Kleine
Anfrage der Abgeordneten Friedrich Ostendorff, Bärbel Höhn, Nicole
Maisch, weiterer Abgeordeter und der Fraktion BÜndnis 90/die
grÜnen.” Drucksache 17/10017. “Daten zur Antibiotikavergabe in Nutz-
tierhaltungen und zum Eintrag von Antibiotika und multiresistenten
Keimen in die Umwelt.” Drucksache 17/10313 [The German Federal Govern-
ment’s response to the minor interpellation from members Friedrich Ostendorff,
Bärbel Höhn, Nicole Maisch, other members, and the ALLIANCE 90/THE
GREENS parliamentary group—Parliamentary record 17/10017. Data on the use
of antibiotics in livestock farming and the contamination of the environment
by antibiotics and multidrug resistant bacteria. Parliamentary record 17/10313],
17 July 2012, at https://dip21.bundestag.de/dip21/btd/17/103/1710313.pdf
(retrieved October 2013). (In German)
Gibney, M.J.; Burstyn, P.G.: “Milk, Serum Cholesterol, and the Maasai—A
Hypothesis.” In: Atherosclerosis. 1980; 35 (3): pp. 339–343.
Gleeson, M. et al.: “Daily Probiotic’s ( Lactobacillus casei Shirota) Reduction of
Infection Incidence in Athletes.” In: Int J Sport Nutr Exerc Metab. 2011 Feb-
ruary; 21 (1): pp. 55–64.
Goldin, B.R.; Gorbach, S.L.: “Clinical Indications for Probiotics: An Overview.”
In: Clinical Infectious Diseases. 2008; 46 (Suppl. 2): pp. s96–s100.
Gorkiewicz, G.: “Contributions of the Physiological Gut Microflora to Health
and Disease.” In: J Gastroenterol Hepatol Erkr. 2009; 7 (1): pp. 15–18.
Grewe, K.: Prävalenz von Salmonella spp. in der primären Geflügelproduktion
und Broilerschlachtung—Salmonelleneintrag bei Schlachtgeflügel während
des Schlachtprozesses [Prevalence of Salmonella spp. in Primary Poultry
Production and the Slaughter of Broiler Chickens—Salmonella Contam-
ination of Slaughter Poultry during the Slaughtering Process]. Hanover:
Hanover University of Veterinary Medicine, 2011. (In German)
Guseo. A.: “The Parkinson Puzzle.” In: Orv Hetil. 2012 December 30; 153 (52):
pp. 2060–2069.
Herbarth, O. et al.: “Helicobacter pylori Colonisation and Eczema.” In: Journal
of Epidemiology and Community Health. 2007; 61 (7): pp. 638–640.
Hullar, M.A.; Lampe, J.W.: “The Gut Microbiome and Obesity.” In: Nestle Nutr
Inst Workshop Ser. 2012; 73: pp. 67–79.
Jernberg, C. et al.: “Long-Term Impacts of Antibiotic Exposure on the Human
Intestinal Microbiota.” In: Microbiology. 2010 November; 156 (Pt. 11): pp.
3216–3223.
Jin, C.; Flavell, R.A.: “Innate Sensors of Pathogen and Stress: Linking Inflam-
mation to Obesity.” In: J Allergy Clin Immunol. 2013 August; 132 (2): pp.
287–294.
Jirillo, E. et al.: “Heathy Effects Exerted by Prebiotics, Probiotics, and Symbi-
otics with Special Reference to Their Impact on the Immune System.” In:
Int J Vitam Nutr Res. 2012 June; 82 (3): pp. 200–208.
Jones, M.L. et al.: “Cholesterol-Lowering Efficacy of a Microencapsulated Bile
Salt Hydrolase-Active Lactobacillus reuteri niMB 30242 Yoghurt Formu-
lation in Hypercholesterolaemic Adults.” In: British Journal of Nutrition.
2012; 107 (10): pp. 1505–1513.
Jumpertz, R. et al.: “Energy-Balance Studies Reveal Associations between Gut
Microbes, Caloric Load, and Nutrient Absorption in Humans.” In: Am J
Clin Nutr. 2011; 94 (1): pp. 58–65.
Katz, S.E.: The Art of Fermentation: An In-Depth Exploration of Essential
Concepts and Processes from around the World. Chelsea: Chelsea Green Pub-
lishing, 2012.
Kountouras, J. et al.: “Helicobacter pylori Infection and Parkinson’s Disease:
Apoptosis as an Underlying Common Contributor.” In: Eur J Neurol. 2012
June; 19 (6): p. e56.
Krznarica, Z. et al.: “Gut Microbiota and Obesity.” In: Dig Dis. 2012; 30: p.
196–200.
Kumar, M. et al.: “Cholesterol-Lowering Probiotics as Potential Biotherapeu-
tics for Metabolic Diseases.” In: Exp Diabetes Res. 2012; 2012: 902917.
Macfarlane, G.T. et al.: “Bacterial Metabolism and Health-Related Effects of
Galactooligosaccharides and Other Prebiotics.” In: J Appl Microbiol. 2008
February; 104 (2): pp. 305–344.
Mann, G.V. et al.: “Atherosclerosis in the Masai.” In: Am J Epidemiol. 1972; 95
(1): pp. 26–37.
Marshall, B.J.: “Unidentified Curved Bacillus on Gastric Epithelium in Active
Chronic Gastritis.” In: Lancet. 1983 June 4; 1 (8336): pp. 1273 ff.
Martinson, V.G. et al.: “A Simple and Distinctive Microbiota Associated with
Honey Bees and Bumble Bees.” In: Mol Ecol. 2011 February; 20 (3): pp.
619–628.
Matamoros, S. et al.: “Development of Intestinal Microbiota in Infants and
Its Impact on Health.” In: Trends Microbiol. 2013 April; 21 (4): pp. 167–173.
Moodley, Y. et al.: “The Peopling of the Pacific from a Bacterial Perspective.”
In: Science. 2009 January 23; 323 (5913): pp. 527–530.
Mori, K. et al.: “Does the Gut Microbiota Trigger Hashimoto’s Thyroiditis?” In:
Discov Med. 2012 November; 14 (78): pp. 321–326.
Musso, G. et al.: “Gut Microbiota as a Regulator of Energy Homeostasis and
Ectopic Fat Deposition: Mechanisms and Implications for Metabolic Dis-
orders.” In: Current Opinion in Lipidology. 2010; 21 (1): pp. 76–83.
Nagpal, R. et al.: “Probiotics, Their Health Benefits and Applications for
Developing Healthier Foods: A Review.” In: FEMS Microbiol Lett. 2012 Sep-
tember; 334 (1): pp. 1–15.
Nakamura, Y.K.; Omaye, S.T.: “Metabolic Diseases and Pro- and Prebiotics:
Mechanistic Insights.” In: Nutr Metab (Lond). 2012 June 19; 9 (1): p. 60.
Nicola, J.P. et al.: “Functional Toll-Like Receptor 4 Conferring Lipopolysac-
charide Responsiveness Is Expressed in Thyroid Cells.” In: Endocrinology.
2009 January; 150 (1): pp. 500–508.
Nielsen, H.H. et al.: “Treatment for Helicobacter pylori Infection and Risk of
Parkinson’s Disease in Denmark.” In: Eur J Neurol. 2012 June; 19 (6): pp.
864–869.
Norris, V. et al.: “Bacteria Control Host Appetites.” In: J Bacteriol. 2013 Febru-
ary; 195 (3): pp. 411–416.
Okusaga, O.; Postolache, T.T.: “Toxoplasma gondii, the Immune System, and
Suicidal Behavior.” In: Dwivedi. Y. (Ed.): The Neurological Basis of Suicide.
Boca Raton, Florida: crc Press, 2012: pp. 159–194.
Ottman, N. et al.: “The Function of Our Microbiota: Who Is Out There and
What Do They Do?” In: Front Cell Infect Microbiol. 2012 August 9; 2: p. 104.
Pavlovíc, N. et al.: “Probiotics-Interactions with Bile Acids and Impact on
Cholesterol Metabolism.” In: Appl Biochem Biotechnol. 2012; 168: pp.
1880–1895.
Petrof, E.O. et al.: “Stool Substitute Transplant Therapy for the Eradications
of Clostridium difficile Infection ‘Repoopulating’ the Gut.” In: Microbiome.
2013 January 9; 1 (1): p. 3.
Reading, N.C.; Kasper, D.L.: “The Starting Lineup: Key Microbial Players in
Intestinal Immunity and Homeostasis.” In: Front Microbiol. 2011 July 7; 2:
p. 148.
Roberfroid, M. et al.: “Prebiotic Effects: Metabolic and Health Benefits.” In: Br
J Nutr. 2010 August; 104 (Suppl. 2): pp. s1–s63.
Sanders, M.E. et al.: “An Update on the Use and Investigation of Probiotics in
Health and Disease.” In: Gut. 2013; 62 (5): pp. 787–796.
Sanza, Y. et al.: “Understanding the Role of Gut Microbes and Probiotics
in Obesity: How Far Are We?” In: Pharmacol Res. 2013 March; 69 (1): pp.
144–155.
Schmidt, C.: “The Startup Bugs.” In: Nat Biotechnol. 2013 April; 31 (4): pp.
279–281.
Scholz-Ahrens, K.E. et al.: “Prebiotics, Probiotics, and Synbiotics Affect Min-
eral Absorption, Bone Mineral Content, and Bone Structure.” In: J Nutr.
2007 March; 137 (3 Suppl. 2): pp. 838s–846s.
Schwarz, S. et al.: “Horizontal versus Familial Transmission of Helicobacter
pylori.” In: PLoS Pathog. 2008 October; 4 (10): p. e1000180.
Shen, J. et al.: “The Gut Microbiota, Obesity and Insulin Resistance.” In: Mol
Aspects Med. 2013 February; 34 (1): pp. 39–58.
Starkenmann, C. et al.: “Olfactory Perception of Cysteine-S–Conjugates from
Fruits and Vegetables.” In: J Agric Food Chem. 2008 October 22; 56 (20): pp.
9575–9580.
Stowell, S.R.: “Innate Immune Lectins Kill Bacteria Expressing Blood Group
Antigen.” In: Nat Med. 2010 March; 16 (3): pp. 295–301.
Tängdén, T. et al.: “Foreign Travel Is a Major Risk Factor for Colonization
with Escherichia coli Producing ctX-M–Type Extended-Spectrum ß-
Lactamases: A Prospective Study with Swedish Volunteers.” In: Antimicrob
Agents Chemother. 2010 September; 54 (9): pp. 3564–3568.
Teixeira, T.F.: “Potential Mechanisms for the Emerging Link between Obesity
and Increased Intestinal Permeability.” In: Nutr Res. 2012 September; 32
(9): pp. 637–647.
Torrey, E.F. et al.: “Antibodies to Toxoplasma gondii in Patients with Schizo-
phrenia: A Meta-Analysis.” In: Schizophr Bull. 2007 May; 33 (3): pp.
729–736.
Tremaroli, V.; Bäckhed, F.: “Functional Interactions between the Gut Micro-
biota and Host Metabolism.” In: Nature. 2012 September 13; 489 (7415):
pp. 242–249.
Turnbaugh, P.J.; Gordon, J.L.: “The Core Gut Microbiome, Energy Balance and
Obesity.” In: J Physiol. 2009; 587 (17): pp. 4153–4158.
de Vrese, M.; Schrezenmeir, J.: “Probiotics, Prebiotics, and Synbtiotics.” In: Adv
Biochem Engin/Biotechnol. 2008; 111: pp. 1–66.
de Vriese, J.: “Medical Research. The Promise of Poop.” In: Science. 2013 August
30; 341 (6149): pp. 954–957.
Vyas, U.; Ranganathan, N.: “Probiotics, Prebiotics and Synbiotics: Gut and
Beyond.” In: Gastroenterol Res Pract. 2012; 2012: 872716.
Webster, J.P. et al.: “Effect of Toxoplasma gondii upon Neophobic Behaviour in
Wild Brown Rats, Rattus norvegicus.” In: Parasitology. 1994 July; 109 (pt. 1):
pp. 37–43.
Wichmann-Schauer, H.: Verbrauchertipps: Schutz vor Lebensmittelinfektionen
im Privathaushalt [Tips: Protection against Food Infections in Private
Households]. Berlin: German Federal Institute for Risk Assessment, 2007.
(In German)
Wu, G.D. et al.: “Linking Long-Term Dietary Patterns with Gut Microbial
Enterotypes.” In: Science. 2011 October 7; 334 (6052): pp. 105–108.
Yatsunenko, T. et al.: “Human Gut Microbiome Viewed across Age and Geog-
raphy.” In: Nature. 2012 May 9; 486 (7402): pp. 222–227.
Zipris, D.: “The Interplay between the Gut Microbiota and the Immune
System in the Mechanism of Type 1 Diabetes.” In: Curr Opin Endocrinol
Diabetes Obes. 2013 August; 20 (4): pp. 265–270.5569